Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial

The intraoperative application of mitomycin c for primary trabeculectomy is associated with potentially sight-threatening side-effects. This study was performed to evaluate the pressure-lowering effect of postoperative application of mitomycin c for primary trabeculectomy and to evaluate the complic...

Full description

Saved in:
Bibliographic Details
Published in:Graefe's archive for clinical and experimental ophthalmology 2006-11, Vol.244 (11), p.1429-1436
Main Authors: Mietz, Holger, Krieglstein, Günter K
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Alkylating Agents - administration & dosage
Female
Fibrosis - prevention & control
Follow-Up Studies
Glaucoma - surgery
Humans
Intraocular Pressure
Male
Middle Aged
Mitomycin - administration & dosage
Ophthalmology
Postoperative Care - methods
Prospective Studies
Sclera - drug effects
Trabeculectomy
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c326t-18a45a6200decc87c5679d47372ce2206c80f11a71797d3228a7a72b79f7ec003
cites cdi_FETCH-LOGICAL-c326t-18a45a6200decc87c5679d47372ce2206c80f11a71797d3228a7a72b79f7ec003
container_end_page 1436
container_issue 11
container_start_page 1429
container_title Graefe's archive for clinical and experimental ophthalmology
container_volume 244
creator Mietz, Holger
Krieglstein, Günter K
description The intraoperative application of mitomycin c for primary trabeculectomy is associated with potentially sight-threatening side-effects. This study was performed to evaluate the pressure-lowering effect of postoperative application of mitomycin c for primary trabeculectomy and to evaluate the complications of this new technique. A randomized, prospective clinical trial with 52 consecutive patients scheduled for glaucoma surgery in one large surgical center was performed. Patients underwent routine trabeculectomy. In group 1, mitomycin c (0.05 mg/ml) was applied topically to the filtering bleb for 5 min on the 3 days after surgery (postoperative application). In group 2, no mitomycin c was applied (controls). The IOP values, visual acuity, number of antiglaucomatous medications and complications were evaluated. Follow-up was evaluated up to 24 months for all patients. The mean intraocular pressure decreased from 31.1 to 15.4 mmHg in group 1 and from 24.8 to 15.6 mmHg in group 2 (P=0.79; t-test). The average number of medications decreased from 2.5 and 2.4 to 0.4 and 0.6 (P=0.53; t-test) in groups 1 and 2, respectively. No cases of hypotony maculopathy occurred. An individual decrease of more than 25% of the IOP was present in 84.6% in group 1 and in 53.8% in group 2 (P
doi_str_mv 10.1007/s00417-005-0217-y
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_230783878</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1164116221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-18a45a6200decc87c5679d47372ce2206c80f11a71797d3228a7a72b79f7ec003</originalsourceid><addsrcrecordid>eNpFkM9KxDAQxoMo7rr6AF4keLY6Sdom9SaL_2BBDwp7C9l0il3apjbtQn0An9uUXfAQMkO-75vJj5BLBrcMQN55gJjJCCCJgIdiPCJzFoskksDXx2QOkrNICb6ekTPvtxDkImGnZMbSJFNxqubk99353rXYmb7cITVtW5U21K6hrqB12bt6tGVDLS3rtnM79LT_Qmpd3VbYI_WDteg9DX6cHG1X1qYbad-ZDdqhQjsl3FMTXpxvQxvG3AR5k7u6_ME8KEtTnZOTwlQeLw73gnw-PX4sX6LV2_Pr8mEVWcHTPmLKxIlJOUCO1ippk1RmeSyF5BY5h9QqKBgzkslM5oJzZaSRfCOzQqIFEAtyvc8N23wP6Hu9dUPXhJGaC5BKqHAWhO1FNqzsOyz04VeagZ7A6z14HcDrCbweg-fqEDxsasz_HQfS4g-nq4GE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230783878</pqid></control><display><type>article</type><title>Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial</title><source>Springer Nature</source><creator>Mietz, Holger ; Krieglstein, Günter K</creator><creatorcontrib>Mietz, Holger ; Krieglstein, Günter K</creatorcontrib><description>The intraoperative application of mitomycin c for primary trabeculectomy is associated with potentially sight-threatening side-effects. This study was performed to evaluate the pressure-lowering effect of postoperative application of mitomycin c for primary trabeculectomy and to evaluate the complications of this new technique. A randomized, prospective clinical trial with 52 consecutive patients scheduled for glaucoma surgery in one large surgical center was performed. Patients underwent routine trabeculectomy. In group 1, mitomycin c (0.05 mg/ml) was applied topically to the filtering bleb for 5 min on the 3 days after surgery (postoperative application). In group 2, no mitomycin c was applied (controls). The IOP values, visual acuity, number of antiglaucomatous medications and complications were evaluated. Follow-up was evaluated up to 24 months for all patients. The mean intraocular pressure decreased from 31.1 to 15.4 mmHg in group 1 and from 24.8 to 15.6 mmHg in group 2 (P=0.79; t-test). The average number of medications decreased from 2.5 and 2.4 to 0.4 and 0.6 (P=0.53; t-test) in groups 1 and 2, respectively. No cases of hypotony maculopathy occurred. An individual decrease of more than 25% of the IOP was present in 84.6% in group 1 and in 53.8% in group 2 (P&lt;0.017). Survival analysis for eyes with a complete surgical success revealed a better outcome of eyes in group 1 as compared to the eyes in group 2 (P&lt;0.013; log-rank test). To our knowledge, this is the first prospective, randomized clinical trial to evaluate the efficacy of postoperative mitomycin c application in primary trabeculectomy. The application of mitomycin significantly reduced the IOP while not increasing the rate of complications.</description><identifier>ISSN: 0721-832X</identifier><identifier>EISSN: 1435-702X</identifier><identifier>DOI: 10.1007/s00417-005-0217-y</identifier><identifier>PMID: 16598468</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Alkylating Agents - administration &amp; dosage ; Female ; Fibrosis - prevention &amp; control ; Follow-Up Studies ; Glaucoma - surgery ; Humans ; Intraocular Pressure ; Male ; Middle Aged ; Mitomycin - administration &amp; dosage ; Ophthalmology ; Postoperative Care - methods ; Prospective Studies ; Sclera - drug effects ; Trabeculectomy ; Treatment Outcome</subject><ispartof>Graefe's archive for clinical and experimental ophthalmology, 2006-11, Vol.244 (11), p.1429-1436</ispartof><rights>Springer-Verlag 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-18a45a6200decc87c5679d47372ce2206c80f11a71797d3228a7a72b79f7ec003</citedby><cites>FETCH-LOGICAL-c326t-18a45a6200decc87c5679d47372ce2206c80f11a71797d3228a7a72b79f7ec003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16598468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mietz, Holger</creatorcontrib><creatorcontrib>Krieglstein, Günter K</creatorcontrib><title>Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial</title><title>Graefe's archive for clinical and experimental ophthalmology</title><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><description>The intraoperative application of mitomycin c for primary trabeculectomy is associated with potentially sight-threatening side-effects. This study was performed to evaluate the pressure-lowering effect of postoperative application of mitomycin c for primary trabeculectomy and to evaluate the complications of this new technique. A randomized, prospective clinical trial with 52 consecutive patients scheduled for glaucoma surgery in one large surgical center was performed. Patients underwent routine trabeculectomy. In group 1, mitomycin c (0.05 mg/ml) was applied topically to the filtering bleb for 5 min on the 3 days after surgery (postoperative application). In group 2, no mitomycin c was applied (controls). The IOP values, visual acuity, number of antiglaucomatous medications and complications were evaluated. Follow-up was evaluated up to 24 months for all patients. The mean intraocular pressure decreased from 31.1 to 15.4 mmHg in group 1 and from 24.8 to 15.6 mmHg in group 2 (P=0.79; t-test). The average number of medications decreased from 2.5 and 2.4 to 0.4 and 0.6 (P=0.53; t-test) in groups 1 and 2, respectively. No cases of hypotony maculopathy occurred. An individual decrease of more than 25% of the IOP was present in 84.6% in group 1 and in 53.8% in group 2 (P&lt;0.017). Survival analysis for eyes with a complete surgical success revealed a better outcome of eyes in group 1 as compared to the eyes in group 2 (P&lt;0.013; log-rank test). To our knowledge, this is the first prospective, randomized clinical trial to evaluate the efficacy of postoperative mitomycin c application in primary trabeculectomy. The application of mitomycin significantly reduced the IOP while not increasing the rate of complications.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alkylating Agents - administration &amp; dosage</subject><subject>Female</subject><subject>Fibrosis - prevention &amp; control</subject><subject>Follow-Up Studies</subject><subject>Glaucoma - surgery</subject><subject>Humans</subject><subject>Intraocular Pressure</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mitomycin - administration &amp; dosage</subject><subject>Ophthalmology</subject><subject>Postoperative Care - methods</subject><subject>Prospective Studies</subject><subject>Sclera - drug effects</subject><subject>Trabeculectomy</subject><subject>Treatment Outcome</subject><issn>0721-832X</issn><issn>1435-702X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpFkM9KxDAQxoMo7rr6AF4keLY6Sdom9SaL_2BBDwp7C9l0il3apjbtQn0An9uUXfAQMkO-75vJj5BLBrcMQN55gJjJCCCJgIdiPCJzFoskksDXx2QOkrNICb6ekTPvtxDkImGnZMbSJFNxqubk99353rXYmb7cITVtW5U21K6hrqB12bt6tGVDLS3rtnM79LT_Qmpd3VbYI_WDteg9DX6cHG1X1qYbad-ZDdqhQjsl3FMTXpxvQxvG3AR5k7u6_ME8KEtTnZOTwlQeLw73gnw-PX4sX6LV2_Pr8mEVWcHTPmLKxIlJOUCO1ippk1RmeSyF5BY5h9QqKBgzkslM5oJzZaSRfCOzQqIFEAtyvc8N23wP6Hu9dUPXhJGaC5BKqHAWhO1FNqzsOyz04VeagZ7A6z14HcDrCbweg-fqEDxsasz_HQfS4g-nq4GE</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>Mietz, Holger</creator><creator>Krieglstein, Günter K</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20061101</creationdate><title>Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial</title><author>Mietz, Holger ; Krieglstein, Günter K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-18a45a6200decc87c5679d47372ce2206c80f11a71797d3228a7a72b79f7ec003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alkylating Agents - administration &amp; dosage</topic><topic>Female</topic><topic>Fibrosis - prevention &amp; control</topic><topic>Follow-Up Studies</topic><topic>Glaucoma - surgery</topic><topic>Humans</topic><topic>Intraocular Pressure</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mitomycin - administration &amp; dosage</topic><topic>Ophthalmology</topic><topic>Postoperative Care - methods</topic><topic>Prospective Studies</topic><topic>Sclera - drug effects</topic><topic>Trabeculectomy</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mietz, Holger</creatorcontrib><creatorcontrib>Krieglstein, Günter K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Proquest Health &amp; Medical Complete</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mietz, Holger</au><au>Krieglstein, Günter K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial</atitle><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><date>2006-11-01</date><risdate>2006</risdate><volume>244</volume><issue>11</issue><spage>1429</spage><epage>1436</epage><pages>1429-1436</pages><issn>0721-832X</issn><eissn>1435-702X</eissn><abstract>The intraoperative application of mitomycin c for primary trabeculectomy is associated with potentially sight-threatening side-effects. This study was performed to evaluate the pressure-lowering effect of postoperative application of mitomycin c for primary trabeculectomy and to evaluate the complications of this new technique. A randomized, prospective clinical trial with 52 consecutive patients scheduled for glaucoma surgery in one large surgical center was performed. Patients underwent routine trabeculectomy. In group 1, mitomycin c (0.05 mg/ml) was applied topically to the filtering bleb for 5 min on the 3 days after surgery (postoperative application). In group 2, no mitomycin c was applied (controls). The IOP values, visual acuity, number of antiglaucomatous medications and complications were evaluated. Follow-up was evaluated up to 24 months for all patients. The mean intraocular pressure decreased from 31.1 to 15.4 mmHg in group 1 and from 24.8 to 15.6 mmHg in group 2 (P=0.79; t-test). The average number of medications decreased from 2.5 and 2.4 to 0.4 and 0.6 (P=0.53; t-test) in groups 1 and 2, respectively. No cases of hypotony maculopathy occurred. An individual decrease of more than 25% of the IOP was present in 84.6% in group 1 and in 53.8% in group 2 (P&lt;0.017). Survival analysis for eyes with a complete surgical success revealed a better outcome of eyes in group 1 as compared to the eyes in group 2 (P&lt;0.013; log-rank test). To our knowledge, this is the first prospective, randomized clinical trial to evaluate the efficacy of postoperative mitomycin c application in primary trabeculectomy. The application of mitomycin significantly reduced the IOP while not increasing the rate of complications.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>16598468</pmid><doi>10.1007/s00417-005-0217-y</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0721-832X
ispartof Graefe's archive for clinical and experimental ophthalmology, 2006-11, Vol.244 (11), p.1429-1436
issn 0721-832X
1435-702X
language eng
recordid cdi_proquest_journals_230783878
source Springer Nature
subjects Adult
Aged
Aged, 80 and over
Alkylating Agents - administration & dosage
Female
Fibrosis - prevention & control
Follow-Up Studies
Glaucoma - surgery
Humans
Intraocular Pressure
Male
Middle Aged
Mitomycin - administration & dosage
Ophthalmology
Postoperative Care - methods
Prospective Studies
Sclera - drug effects
Trabeculectomy
Treatment Outcome
title Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A56%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Postoperative%20application%20of%20mitomycin%20c%20improves%20the%20complete%20success%20rate%20of%20primary%20trabeculectomy:%20a%20prospective,%20randomized%20trial&rft.jtitle=Graefe's%20archive%20for%20clinical%20and%20experimental%20ophthalmology&rft.au=Mietz,%20Holger&rft.date=2006-11-01&rft.volume=244&rft.issue=11&rft.spage=1429&rft.epage=1436&rft.pages=1429-1436&rft.issn=0721-832X&rft.eissn=1435-702X&rft_id=info:doi/10.1007/s00417-005-0217-y&rft_dat=%3Cproquest_cross%3E1164116221%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c326t-18a45a6200decc87c5679d47372ce2206c80f11a71797d3228a7a72b79f7ec003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230783878&rft_id=info:pmid/16598468&rfr_iscdi=true